July 5, 2021 by Dave Wendland
Dave Wendland, Hamacher Resource Group Inc.
July 5, 2021, Opinion

The use of technology has been expanding across retail for years — however, its pervasiveness was accelerated by the COVID-19 pandemic. The integration of technology within the retail ecosystem has become the new normal. This article highlights five technological advancements that have changed the shape of health care delivery and the retail supply chain forever.
August 20, 2020 by Chain Drug Review
Dave Wendland, Hamacher Resource Group (HRG), International Paper, Jeffrey Guillebeau
Leading Headlines, Retail News, Supplier News

WAUKESHA, Wis. – Hamacher Resource Group (HRG) is lending their assortment planning and placement expertise to International Paper’s (IP) Retail division to enhance their existing Multi-Vendor Program (MVP) and offer retailers the Shopper Solution Center. These free-standing retail displays are available in a variety of sizes and feature a curated product assortment consisting of multiple
November 20, 2017 by Dave Wendland and Chain Drug Review
Dave Wendland, emerging retail categories, Hamacher Resource Group, retail health care
2017, Issue 11-20-2017, Issues, Opinion

New categories can develop when product innovation meets a consumer’s unmet need in a way that no existing category has provided. Retailers that adopt a new category or subcategory early can gain an edge over their competitors. Emerging retail categories disrupt and change the retail market. There are innovative retail categories that include virtual reality
August 22, 2017 by Chain Drug Review
Dave Wendland, Forbes Agency Council, Hamacher Resource Group, HRG
Supplier News

WAUKESHA, Wis. — Dave Wendland, vice president of strategic relations and member of the owners group at Hamacher Resource Group Inc. (HRG), has been accepted into the Forbes Agency Council. The Forbes Agency Council is an invitation-only community for executives in successful public relations, media strategy, creative and advertising agencies. Hamacher said Tuesday that Wendland
February 9, 2017 by Chain Drug Review
Dave Wendland, Dawn Vogelsang, Hamacher Resource Group, HRG
Supplier News

WAUKESHA, Wis. — Dave Wendland, vice president of strategic relations and an owners group member at Hamacher Resource Group (HRG), is celebrating his 25th year at the company in 2017. Wendland serves as HRG’s primary liaison to trade associations, industry publications and alliance partners. He also assists the business development team, providing insights to offer
August 11, 2016 by Chain Drug Review
Dave Wendland, Hamacher Resource Group, Jen Johnston, Marjorie Newman, Martin Newman, NovaGenesis, Recovery Skin Relief, skin care
Business, Supplier News

WAUKESHA, Wis. — With some go-to-market guidance from Hamacher Resource Group, NovaGenesis LLC is set to launch its Recovery Skin Relief therapeutic skin care line at retail pharmacies next month. Hamacher said that in the wake of a collaborative strategy session a year ago, it worked with NovaGenesis to devise a road map for the
June 20, 2016 by Dave Wendland and Chain Drug Review
Dave Wendland, Hamacher Resource Group, industry consolidation, mergers and acquisitions
2016, Issue 06-20-2016, Issues, Opinion

The aftermath of mergers and acquisitions or other industry “disruptions” can be unsettling, to say the least. The dust is often kicked up, and the traditional foundation feels shaky at best. A June 2014 article by McKinsey & Co., “How U.S. health care companies can thrive amid disruption,” states that the volume of M&A deal
February 2, 2016 by Chain Drug Review
Dave Wendland, Dawn Vogelsang, Hamacher Resource Group, Sean Grudzinski, Shawn Theesfeld
Supplier News

WAUKESHA, Wis. — Hamacher Resource Group Inc. has expanded its ownership team. The consumer health care at retail marketing specialist said Tuesday that product research and analysis manager Sean Grudzinski and software/web development lead Shawn Theesfeld have joined the company’s ownership team, bringing the total number of employee owners to eight. This month, Grudzinski will
December 18, 2015 by Dave Wendland and Chain Drug Review
Apple Watch, Dave Wendland, Fitbit, Hamacher Resource Group, wearables
Opinion, Technology

Putting patients increasingly in control of their well-being and health care outcomes has truly come of age. It is through technology that the ability to automatically monitor, track and report a health condition has become attainable, and this is another positive step toward equipping consumers to be in charge of their health. This technology will
June 22, 2015 by Chain Drug Review and Chain Drug Review
community pharmacies, Dave Wendland, Hamacher Resource Group, Health Mart, McKesson, McKesson ideaShare 2015, Tom Boyer
Supplier News
WAUKESHA, Wis. — Dave Wendland, vice president and member of the owners group at Hamacher Resource Group Inc., is slated to present a continuing education session, “Seven Deadly Sins of Community Pharmacy,” this week at the McKesson ideaShare 2015 conference in San Diego. The presentation, to be held June 25 from 1:30-3:00 p.m., will focus on